February 2025
·
75 Reads
The MRI-visible axon radius is a potential clinical biomarker for, e.g., neurological disorders. However, its clinical potential remains untapped, as in-vivo MRI-based estimation lacks validation in humans and currently requires specialized research scanners. Here, we assess state-of-the-art MRI methods for axon radius estimation against a new, open-access histological gold standard of two densely sampled human corpora callosa, enabling validation via quantitative spatial correlations. Our findings show a significant correlation between estimates from histology and in-vivo dMRI acquired with a research scanner. Critically, our simulations suggest that these findings can be translated from research to clinical scanners, enabling clinical adoption. We propose specific clinical scanner protocols and illustrate their potential in a hypothetical application distinguishing individuals with autism spectrum disorder from healthy controls. Overall, our study provides promising evidence for the validity of the MRI-visible axon radius and outlines a pathway to its clinical application, while critically discussing remaining challenges.